Zyban /Wellbutrin (Bupropion) Warning

[Guest guest]

In a message dated 8/17/02 5:04:13 AM Mountain Daylight Time,

israelswarrior@... writes:

> This is not nicotine or a nicotine patch.

>

> Zyban is a psychiatric drug, another among the many, being used to

> lobotomize this population.

>

>

Well, well, well, Zyban gets a blurb in my book, too. Along with Serafem and

all the other drugs that have had their names changed to lure in the

innocent.

Glitter, author of <A HREF= " www.xlibris.com/BlindReason.html " >Blind Reason</A>

[Guest guest]

In a message dated 8/17/02 5:04:13 AM Mountain Daylight Time,

israelswarrior@... writes:

> This is not nicotine or a nicotine patch.

>

> Zyban is a psychiatric drug, another among the many, being used to

> lobotomize this population.

>

>

Well, well, well, Zyban gets a blurb in my book, too. Along with Serafem and

all the other drugs that have had their names changed to lure in the

innocent.

Glitter, author of <A HREF= " www.xlibris.com/BlindReason.html " >Blind Reason</A>

[Guest guest]

You may know someone on Zyban (bupropion)

For your information and so you won't get caught by the promo, Zyban is a

drug which alters brain chemistry, structure and function. It is, in other

words, a mind altering drug, much like any of the other so called

antidepressants.

This same drug is sold under the brand name, Wellbutrin (bupropion), as an

antidepressant.

The " reported " deaths and the more serious " reported " adverse reactions

below, represent less than one percent of the actual occurrences.

This is not nicotine or a nicotine patch.

Zyban is a psychiatric drug, another among the many, being used to

lobotomize this population.

If you or someone you know has been prescribed this drug without full

disclosure, you should know that withdrawal can be a " bitch. " It is

addictive (it produces a withdrawal syndrome) and can produce weird

" psychiatric " symptoms.

Consult both a competent, non psychiatric physician upon withdrawal and

secure a competent legal council.

ARC,

Dennis H. e

Anti-smoking drug deaths triple

Zyban : under close review

The number of people who have died after taking the anti-smoking drug Zyban

has more than tripled in a year, official figures show.

By January 10, 57 people had died following suspected adverse reactions to

the drug, compared to 18 the same time last year, the Medicines Control

Agency (MCA) found.

But the MCA said a direct link between the drug, which was launched in June

2000, and the deaths was unproven.

And anti-smoking campaigners said most of the deaths would have occurred

anyway.

Data on adverse reactions to the drug was reported by doctors, dentists,

pharmacists, coroners and pharmaceutical companies under the government's

" yellow card " scheme.

There is currently no reason to believe that patients taking Zyban have an

increased risk of death

GlaxoKline spokesman

In a notice published on its website, the MCA said: " There have been 57

reports of suspected adverse reactions to Zyban which have resulted in a

fatal outcome.

" The contribution of Zyban to these fatal cases is unproven and in the

majority of cases the individual's underlying condition may provide an

alternative explanation.

" In 14 of these reports the individual was not taking Zyban at the time of

their death. "

Raised awareness

The MCA has received 6,975 reports of suspected adverse reactions to Zyban,

including insomnia, rashes, headache, nausea, vomiting and depression.

Of those, 168 patients suffered seizures suspected as being associated with

Zyban.

As with all new drugs, the safety of Zyban remains under close review

Medicines Control Agency spokesman

A spokesman for the MCA said the figures were an update to keep people aware

of the position.

" As with all new drugs, the safety of Zyban remains under close review. "

He added: " Comparing Zyban with other medicines, the proportion of Zyban

reports that have fatal outcomes is much lower - less than 1%. "

Doctors and pharmacists will be asked to continue reporting all suspected

adverse reactions to the MCA and the Committee on Safety of Medicines, an

expert advisory group.

A spokesman for pharmaceutical giant GlaxoKline, which makes the drug,

said: " Smoking-related disease claims 320 lives a day in the UK.

" There is currently no reason to believe that patients taking Zyban have an

increased risk of death.

" There is no proven link with deaths and the medicine is used in patients

who are already at risk because of smoking.

Clive Bates, of Action on Smoking and Health, told BBC News Online said:

" Most of these people would have died anyway.

" It's important not to confuse deaths that happen while using the drug with

deaths that happen because of using the drug. "

He added that over 400,000 people have used Zyban.

_________________________________________________________________

Send and receive Hotmail on your mobile device: http://mobile.msn.com

[Guest guest]

You may know someone on Zyban (bupropion)

For your information and so you won't get caught by the promo, Zyban is a

drug which alters brain chemistry, structure and function. It is, in other

words, a mind altering drug, much like any of the other so called

antidepressants.

This same drug is sold under the brand name, Wellbutrin (bupropion), as an

antidepressant.

The " reported " deaths and the more serious " reported " adverse reactions

below, represent less than one percent of the actual occurrences.

This is not nicotine or a nicotine patch.

Zyban is a psychiatric drug, another among the many, being used to

lobotomize this population.

If you or someone you know has been prescribed this drug without full

disclosure, you should know that withdrawal can be a " bitch. " It is

addictive (it produces a withdrawal syndrome) and can produce weird

" psychiatric " symptoms.

Consult both a competent, non psychiatric physician upon withdrawal and

secure a competent legal council.

ARC,

Dennis H. e

Anti-smoking drug deaths triple

Zyban : under close review

The number of people who have died after taking the anti-smoking drug Zyban

has more than tripled in a year, official figures show.

By January 10, 57 people had died following suspected adverse reactions to

the drug, compared to 18 the same time last year, the Medicines Control

Agency (MCA) found.

But the MCA said a direct link between the drug, which was launched in June

2000, and the deaths was unproven.

And anti-smoking campaigners said most of the deaths would have occurred

anyway.

Data on adverse reactions to the drug was reported by doctors, dentists,

pharmacists, coroners and pharmaceutical companies under the government's

" yellow card " scheme.

There is currently no reason to believe that patients taking Zyban have an

increased risk of death

GlaxoKline spokesman

In a notice published on its website, the MCA said: " There have been 57

reports of suspected adverse reactions to Zyban which have resulted in a

fatal outcome.

" The contribution of Zyban to these fatal cases is unproven and in the

majority of cases the individual's underlying condition may provide an

alternative explanation.

" In 14 of these reports the individual was not taking Zyban at the time of

their death. "

Raised awareness

The MCA has received 6,975 reports of suspected adverse reactions to Zyban,

including insomnia, rashes, headache, nausea, vomiting and depression.

Of those, 168 patients suffered seizures suspected as being associated with

Zyban.

As with all new drugs, the safety of Zyban remains under close review

Medicines Control Agency spokesman

A spokesman for the MCA said the figures were an update to keep people aware

of the position.

" As with all new drugs, the safety of Zyban remains under close review. "

He added: " Comparing Zyban with other medicines, the proportion of Zyban

reports that have fatal outcomes is much lower - less than 1%. "

Doctors and pharmacists will be asked to continue reporting all suspected

adverse reactions to the MCA and the Committee on Safety of Medicines, an

expert advisory group.

A spokesman for pharmaceutical giant GlaxoKline, which makes the drug,

said: " Smoking-related disease claims 320 lives a day in the UK.

" There is currently no reason to believe that patients taking Zyban have an

increased risk of death.

" There is no proven link with deaths and the medicine is used in patients

who are already at risk because of smoking.

Clive Bates, of Action on Smoking and Health, told BBC News Online said:

" Most of these people would have died anyway.

" It's important not to confuse deaths that happen while using the drug with

deaths that happen because of using the drug. "

He added that over 400,000 people have used Zyban.

_________________________________________________________________

Send and receive Hotmail on your mobile device: http://mobile.msn.com

[Guest guest]

on 17/8/02 9:38 AM, glitterari@... at glitterari@... wrote:

> Well, well, well, Zyban gets a blurb in my book, too. Along with Serafem and

> all the other drugs that have had their names changed to lure in the

> innocent.

Yes recently saw tests for CFS of fluoxetine and thought sneaky bastids

[Guest guest]

on 17/8/02 9:38 AM, glitterari@... at glitterari@... wrote:

> Well, well, well, Zyban gets a blurb in my book, too. Along with Serafem and

> all the other drugs that have had their names changed to lure in the

> innocent.

Yes recently saw tests for CFS of fluoxetine and thought sneaky bastids